Abstract
The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Curcumin / analogs & derivatives*
-
Curcumin / chemistry
-
Curcumin / pharmacology
-
Humans
-
Molecular Structure
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / chemistry
-
Platelet Aggregation Inhibitors / pharmacology*
Substances
-
Platelet Aggregation Inhibitors
-
hexahydrocurcumin
-
Curcumin